Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells.
Journal: The Journal of clinical investigation
Published: March 04, 2025
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells.
Journal: Science immunology
Published: March 10, 2023
Synthesis of 2-Oxoquinoline Derivatives as Dual Pim and mTORC Protein Kinase Inhibitors.
Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Published: November 17, 2022
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.
Journal: The Journal of cell biology
Published: August 26, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
Journal: Cancer
Published: April 26, 2022
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 06, 2021
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report.
Journal: Journal of medical case reports
Published: February 24, 2021
PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.
Journal: Molecular cancer therapeutics
Published: March 03, 2020
Last Updated: 09/26/2026